Robert A. Montgomery

Active 1991–2025

167
Papers
24,398
Citations
95
h-index
161
i10-index

Citations

Citations per year for Robert A. Montgomery1992: 6 citations1993: 8 citations1994: 5 citations1995: 7 citations1996: 11 citations1997: 13 citations1998: 14 citations1999: 22 citations2000: 44 citations2001: 42 citations2002: 24 citations2003: 54 citations2004: 92 citations2005: 104 citations2006: 97 citations2007: 120 citations2008: 122 citations2009: 131 citations2010: 138 citations2011: 179 citations2012: 144 citations2013: 124 citations2014: 166 citations2015: 177 citations2016: 136 citations2017: 152 citations2018: 158 citations2019: 509 citations2020: 565 citations2021: 525 citations2022: 428 citations2023: 327 citations2024: 649 citations2025: 405 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,067 citing papers, 34% of this breakdownUnited Kingdom: 414 citing papers, 6.8% of this breakdownFrance: 368 citing papers, 6% of this breakdownCanada: 330 citing papers, 5.4% of this breakdownGermany: 302 citing papers, 5% of this breakdownChina: 231 citing papers, 3.8% of this breakdownNetherlands: 220 citing papers, 3.6% of this breakdownSpain: 216 citing papers, 3.6% of this breakdownItaly: 211 citing papers, 3.5% of this breakdownAustralia: 165 citing papers, 2.7% of this breakdownBelgium: 153 citing papers, 2.5% of this breakdownSwitzerland: 130 citing papers, 2.1% of this breakdown
0%34%Other 21%

Fields

  • Medicine80.7%
  • Immunology and Microbiology5.7%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Environmental Science2.6%
  • Computer Science2%
  • Engineering1.2%
  • Other3.2%

Topics

  • Renal Transplantation Outcomes and Treatments14.7%
  • Organ Transplantation Techniques and Outcomes8%
  • Organ Donation and Transplantation8%
  • Transplantation: Methods and Outcomes3.9%
  • Renal and Vascular Pathologies3.1%
  • Renal Diseases and Glomerulopathies2.8%
  • Other59.5%

Coauthors

All papers

Open in search
  1. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marion Rabant, Lorraine C. Racusen, Parmjeet Randhawa, Blaise Robin, Ivy A. Rosales, Ruth Sapir‐Pichhadze, Carrie A. Schinstock, Daniel Serón, Harsharan K. Singh, R. Neal Smith, Mark D. Stegall, Adriana Zeevi, Kim Solez, Robert B. Colvin, Michael Mengel - American Journal of Transplantation 2020 cited by 808

  2. Results of Two Cases of Pig-to-Human Kidney Xenotransplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 474

  3. Pig-to-human heart xenotransplantation in two recently deceased human recipients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Monahan, Lori Sorrells, Lars Burdorf, Jef D. Boeke, Harvey I. Pass, Chandra Goparaju, Brendan J. Keating, David Ayares, Marc I. Lorber, Adam Griesemer, Sameer Mehta, Deane E. Smith, Robert A. Montgomery - Nature Medicine 2023 cited by 169

  4. Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 151

  5. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation 2019 cited by 331

  6. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2019 cited by 343

  7. Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States

    Authors: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2021 cited by 95

  8. Risk of End-Stage Renal Disease Following Live Kidney Donation

    Authors: , , , , , , - JAMA 2014 cited by 978

  9. Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients

    Authors: , , , , , , , , , , , , , - American Journal of Transplantation 2021 cited by 92

  10. HLA in transplantation

    Authors: , , , - Nature Reviews Nephrology 2018 cited by 170

  11. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

    Authors: , , , , , , , , , , , , , , , - Transplantation 2020 cited by 114

  12. Integrative multi-omics profiling in human decedents receiving pig heart xenografts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph Sall, Alexandre Loupy, Adriana Heguy, Sarah E. Taylor, Yinan Zhu, Basil Michael, Lihua Jiang, Ruiqi Jian, Anita S. Chong, Robert L. Fairchild, Suvi Linna-Kuosmanen, Minna U. Kaikkonen, Vasishta Tatapudi, Marc I. Lorber, David Ayares, Massimo Mangiola, Navneet Narula, Nader Moazami, Harvey I. Pass, Ramin S. Herati, Adam Griesemer, Manolis Kellis, M Snyder, Robert A. Montgomery, Jef D. Boeke, Brendan J. Keating - Nature Medicine 2024 cited by 57

  13. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Osama Gaber, Robert A. Montgomery, Dorry L. Segev - New England Journal of Medicine 2016 cited by 351

  14. The decedent model: A new paradigm for de-risking high stakes clinical trials like xenotransplantation

    Authors: , , , - American Journal of Transplantation 2024 cited by 38

  15. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

    Authors: , , , , , , , , , , - American Journal of Transplantation 2019 cited by 146

  16. Response to American College of Physician’s statement on the ethics of transplant after normothermic regional perfusion

    Authors: , , , - American Journal of Transplantation 2022 cited by 69

  17. Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients

    Authors: , , , , , , , , , , , , - Annals of Surgery 2016 cited by 180

  18. Desensitization in HLA-Incompatible Kidney Recipients and Survival

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 676

  19. “Big Data” in the Intensive Care Unit. Closing the Data Loop

    Authors: , , , - American Journal of Respiratory and Critical Care Medicine 2013 cited by 204

  20. Practical advice on variable selection and reporting using Akaike information criterion

    Authors: , , , , , - Royal Society B Biological Sciences, Proceedings of the Royal Society B Biological Sciences 2023 cited by 187

  21. The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Kozakowski, Helen Liapis, Massimo Mangiola, Robert A. Montgomery, Brian Nankinvell, Desley Neil, Peter Nickerson, Marion Rabant, Parmjeet Randhawa, Leonardo V. Riella, Ivy A. Rosales, Virginie Royal, Ruth Sapir‐Pichhadze, Pinaki Sarder, Minnie Sarwal, Carrie A. Schinstock, Mark D. Stegall, Kim Solez, Jeroen van der Laak, Chris Wiebe, Robert B. Colvin, Alexandre Loupy, Michael Mengel - American Journal of Transplantation 2023 cited by 49

  22. Cellular dynamics in pig-to-human kidney xenotransplantation

    Authors: , , , , , , , , , , , , , , , , , , , , - Med 2024 cited by 39

  23. IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody

    Authors: , , , , , , , , , , - Annals of Surgery 2018 cited by 112

  24. Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John J. Friedewald, Xavier Jouven, Christophe Legendre, Carmen Lefaucheur, Alexandre Loupy - The Lancet Digital Health 2021 cited by 65